These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15755587)

  • 21. Ancestral and consensus envelope immunogens for HIV-1 subtype C.
    Kothe DL; Li Y; Decker JM; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Weng Z; Weaver EA; Gao F; Haynes BF; Shaw GM; Korber BT; Hahn BH
    Virology; 2006 Sep; 352(2):438-49. PubMed ID: 16780913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
    Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
    Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody markers of incident tuberculosis among HIV-infected adults in the USA: a historical prospective study.
    Gennaro ML; Affouf M; Kanaujia GV; Brusasca PN; Mangura B; Reichman L
    Int J Tuberc Lung Dis; 2007 Jun; 11(6):624-31. PubMed ID: 17519093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
    Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
    AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
    Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
    Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
    Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
    Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV/AIDS research. Potent HIV antibodies spark vaccine hopes.
    Cohen J
    Science; 2009 Sep; 325(5945):1195. PubMed ID: 19729632
    [No Abstract]   [Full Text] [Related]  

  • 32. Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma.
    Humbert M; Antoni S; Brill B; Landersz M; Rodes B; Soriano V; Wintergerst U; Knechten H; Staszewski S; von Laer D; Dittmar MT; Dietrich U
    Eur J Immunol; 2007 Feb; 37(2):501-15. PubMed ID: 17236253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.
    Donaghy L; Gros F; Amiot L; Mary C; Maillard A; Guiguen C; Gangneux JP
    Clin Exp Immunol; 2007 Feb; 147(2):236-40. PubMed ID: 17223963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy.
    D'Orsogna LJ; Krueger RG; McKinnon EJ; French MA
    AIDS; 2007 Aug; 21(13):1747-52. PubMed ID: 17690573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening HIV-1 antigenic peptides as receptors for antibodies and CD4 in allosteric nanosensors.
    Ferraz RM; Rodríguez-Carmona E; Ferrer-Miralles N; Meyerhans A; Villaverde A
    J Mol Recognit; 2009; 22(3):255-60. PubMed ID: 19177495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting carbohydrate antigens in HIV vaccine development.
    Pashov A; Canziani G; Macleod S; Plaxco J; Monzavi-Karbassi B; Kieber-Emmons T
    Vaccine; 2005 Mar; 23(17-18):2168-75. PubMed ID: 15755589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
    Alving CR; Beck Z; Karasavva N; Matyas GR; Rao M
    Mol Membr Biol; 2006; 23(6):453-65. PubMed ID: 17127618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.